CIK 0000906709 · Non-accelerated filer<br>Smaller reporting company
NEKTAR THERAPEUTICS
Sign in to watch- Ticker
- NKTR
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 943134940
- Phone
- 4154825300
- Business address
- 455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
- Former names
- INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $43,476
- in 2 filings
Net −$43,476. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-12-12 | Labrucherie Gil M SVP, COO & CFO | Grant or award · Stock Option | +29,000 | 29,000 | ||
| 2019-12-02 | NORTHCOTT JOHN SVP & Chief Commercial Officer | Grant or award | +200,000 | 200,000 | ||
| 2019-12-02 | NORTHCOTT JOHN SVP & Chief Commercial Officer | Grant or award · Stock Option | +200,000 | 200,000 | ||
| 2019-11-18 | Zalevsky Jonathan Chief R&D Officer | Sale | −3,960 | $17.97 | $71K | 291,697 |
| 2019-11-18 | Thomsen Jillian B. SVP & Chief Accounting Officer | Sale | −2,713 | $17.97 | $49K | 160,441 |
| 2019-11-18 | ROBIN HOWARD W President & CEO | Sale | −13,556 | $17.97 | $244K | 299,219 |
| 2019-11-18 | Labrucherie Gil M SVP, COO & CFO | Sale | −8,863 | $17.97 | $159K | 219,009 |
| 2019-11-13 | Labrucherie Gil M SVP, COO & CFO | Option exercise | +25,000 | $7.21 | $180K | 252,872 |
| 2019-11-13 | Labrucherie Gil M SVP, COO & CFO | Sale | −25,000 | $19.79 | $495K | 227,872 |
| 2019-11-13 | Labrucherie Gil M SVP, COO & CFO | Option exercise · Stock Option | −25,000 | 0 | ||
| 2019-10-17 | ROBIN HOWARD W President & CEO | Option exercise | +33,333 | $7.21 | $240K | 346,108 |
| 2019-10-17 | ROBIN HOWARD W President & CEO | Sale | −33,333 | $17.68 | $589K | 312,775 |
| 2019-10-17 | ROBIN HOWARD W President & CEO | Option exercise · Stock Option | −33,333 | 0 | ||
| 2019-10-16 | ROBIN HOWARD W President & CEO | Option exercise | +33,334 | $7.21 | $240K | 346,109 |
| 2019-10-16 | ROBIN HOWARD W President & CEO | Sale | −33,334 | $17.48 | $583K | 312,775 |
| 2019-10-16 | ROBIN HOWARD W President & CEO | Option exercise · Stock Option | −33,334 | 33,333 | ||
| 2019-10-15 | ROBIN HOWARD W President & CEO | Option exercise | +33,333 | $7.21 | $240K | 346,108 |
| 2019-10-15 | ROBIN HOWARD W President & CEO | Sale | −8,833 | $16.35 | $144K | 337,275 |
| 2019-10-15 | ROBIN HOWARD W President & CEO | Sale | −24,500 | $17.17 | $421K | 312,775 |
| 2019-10-15 | ROBIN HOWARD W President & CEO | Option exercise · Stock Option | −33,333 | 66,667 |
Page 22 of 29 · 562 trades